Cardea Bio, a Tech+Bio company that has integrated molecular biology with semiconductor electronics, today announced that Dawn Barry has joined the company’s Board of Directors. Dawn Barry is the President & co-founder of LunaPBC, Inc., which was named by the World Economic Forum as a Technology Pioneer in 2019. SAN DIEGO — Cardea technology taps […]

Supports accelerated growth of R&D, manufacturing, and commercial activities with new 100,000 sq-ft state-of-the-art facility Reinforces commitment to the region as Abcam approaches 20 years of US presence Cambridge, UK: Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life sciences reagents and tools, today announces the opening of a major new site in Waltham, MA. The new facility […]

UPPSALA, Sweden — Olink Holding AB (publ) (Nasdaq: OLK) today announced that deCODE genetics, a global leader in analyzing and understanding the human genome, will have internal access to the Olink® Explore 3072 platform, comprised of approximately 3,000 high quality protein assays with a Next Generation Sequencing (NGS) read-out. Through an agreement between the two […]

NEW YORK & BOULDER, Colo. — CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, Inc., a leader in proteomics technology, announced today that Beth Israel Deaconess Medical Center’s (BIDMC) Genomics, Proteomics, Bioinformatics, and Systems Biology Center in Boston, Mass. will be the first site to offer the 7,000-plex SomaScan® Assay kits in their core lab […]

Collaboration is poised to deliver a range of ready-to-use bioprocess impurity reagent sets optimized for use with the Gyrolab platform New reagent set effectively detects host cell impurities from HEK 293 cells used in vaccine and viral vector manufacturing for cell and gene therapies, and vaccines Uppsala, Sweden: Gyros Protein Technologies (part of Mesa Labs’ Biopharmaceutical Development […]

Boulder, CO – July 1, 2021– InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial availability of its VaxArray® Polio D-antigen quantification kit for rapid and accurate assessment of polio vaccines at all stages of manufacturing, including multivalent drug product. InDevR’s […]

NEW YORK & BOULDER, Colo. — CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, Inc., a global leader in proteomics technology, announced today that their new customizable protein panel products are now available to pharma, biotechnology and academic research customers seeking the power of the company’s proteomics menu of 7,000 proteins. “Our customers have expressed […]

Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tools for the job, launched a new application suite for the characterization of nanoparticles on Stunner today. Stunner is already the go-to solution for AAV titer and empty/full ratio measurements, and now it takes on payload quant […]

Leatherhead, UK – Protein Stable and F-star Therapeutics have entered into a collaboration to explore the benefits of the high throughput SUPR-CM platform for early development, lead selection, formulation development and stability prediction. Jon Armer, Formulation Lead Senior Scientist at F-star commented: “At F-star, we are developing next generation tetravalent bispecifics for cancer immunotherapy which […]

Pleasanton, Calif.—Apton Biosystems, Inc., a developer of Super-Res sequencing and single-molecule detection systems for large-scale clinical applications, such as early cancer detection and population sequencing, today announced the close of a $24 million Series-A financing. The financing was led by Kern Capital with participation by new and existing investors including Casdin Capital and Khosla Ventures. […]